Fresenius Kabi Weighs Potential Of Warning Letter For Melrose Park
Deficient Plant A Significant Issue For Kabi
Fresenius Kabi discussed the latest around the potential of an FDA warning letter at its key injectables plant in Melrose Park, after earlier this year confirming that no product launches from the site were anticipated in 2021.
